Article
Prevalence of Mendelian kidney disease among patients with high-risk<i>APOL1</i>genotypes undergoing commercial genetic testing in the United States
2024-02-14
Abstract excerpt
<h4>ABSTRACT</h4> <h4>Background</h4> Among individuals with high-risk APOL1 genotypes, the lifetime risk of developing kidney failure is ∼15%, indicating that other genetic variants or non-genetic modifiers likely contribute substantially to an individual patient’s risk of progressive kidney disease. Here we estimate the prevalence and distribution of molecularly diagnosed Mendelian kidney diseases among patients...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 2e34b292-3135-5c93-bc00-d984516e6913
- DOI
- 10.1101/2024.02.13.24302777
